In Brief: First Medical, Inc.
This article was originally published in The Gray Sheet
First Medical, Inc.: Walter Narajowski is named president and CEO. Narajowski formerly served as VP and general manager of the Abbott Hospital Product Division's infusion pumps and critical care products businesses. Former President and CEO David McCaslin left last summer by mutual agreement with the board, the company explains. First Medical also announces the submission in December of a 510(k) submission to FDA for its Alpha Dx clinical decision support system. The device uses whole blood "for the rapid, quantitative and simultaneous measurement of a panel of tests," including myoglobin, CK, CK-MB, relative index and troponin I, "to aid in the diagnosis of acute myocardial infarction"...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.